COmapper: high-resolution mapping of meiotic crossovers by long-read sequencing in Arabidopsis
This article introduces COmapper, a novel pipeline for high-resolution mapping of meiotic crossovers in Arabidopsis using long-read nanopore sequencing technology. The COmapper tool was validated against existing short-read sequencing methods and demonstrated comparable accuracy for detecting crossovers in pooled DNA from F1 hybrid pollen and F2 recombinant seedlings. The study used COmapper to analyze crossover patterns in wild-type and recq4a recq4b mutants, showing that crossovers are enriched at gene-proximal promoters and influenced by polymorphism density, making it a versatile tool for studying meiotic recombination across various plant species.
Access Investment Management LLC Purchases 66,660 Shares of John Wiley & Sons, Inc. $WLY
Access Investment Management LLC increased its stake in John Wiley & Sons (NYSE:WLY) by 74.7% during Q3, acquiring 66,660 additional shares to hold a total of 155,940 shares valued at approximately $6.31 million. The article highlights the company's Q3 earnings beat, revenue figures, FY2026 EPS guidance, and its quarterly dividend. Several other institutional investors have also adjusted their positions in John Wiley & Sons.
Is Rising Capital Needs Amid Soft Demand Altering The Investment Case For John Wiley & Sons (WLY)?
John Wiley & Sons is facing challenges due to declining sales, compressing free cash flow margins, and increased capital consumption to maintain competitiveness. This situation raises concerns about the company's long-term growth potential and puts pressure on its investment narrative, despite some investors viewing the stock as potentially undervalued. The article suggests investors should consider various perspectives and conduct thorough research on the company's financial health and future prospects.
John Wiley & Sons (NYSE:WLYB) Sees Strong Trading Volume - What's Next?
John Wiley & Sons (NYSE:WLYB) experienced unusually strong trading volume on Monday, with 1,544 shares traded, a 169% increase from the previous session. The company reported strong quarterly earnings, beating estimates by $0.32 per share, and declared a quarterly dividend of $0.355, resulting in a 4.4% yield. Analysts currently hold a "Hold" rating on the stock based on MarketBeat.com data.
John Wiley & Sons (NYSE:WLYB) Shares Gap Down - Time to Sell?
John Wiley & Sons (WLYB) stock gapped down to $31.14 on Friday, trading on very light volume, and remains below its 50-day and 200-day moving averages. Despite solid quarterly earnings per share ($1.10 vs. $0.78 consensus) and revenue ($421.8M), and a 4.6% dividend yield, analysts maintain a "Hold" rating. The company's financial metrics include a P/E of 16.6, market cap of $1.64B, and current/quick ratios below 1.
John Wiley & Sons, Inc. (NYSE:WLYB) Short Interest Up 330.1% in December
John Wiley & Sons, Inc. (NYSE:WLYB) experienced a significant surge in short interest in December, increasing by 330.1% to 2,628 shares. This rise comes as the company beat quarterly earnings estimates, announcing an EPS of $1.10 and revenue of $421.8 million, along with a quarterly dividend of $0.355. Despite positive financial results and a "Hold" rating from analysts, the stock traded down about 6.3% on Thursday.
Brown Advisory Inc. Buys 43,894 Shares of John Wiley & Sons, Inc. $WLY
Brown Advisory Inc. increased its stake in John Wiley & Sons, Inc. by 3.7% in the second quarter, adding 43,894 shares to now own 1,228,848 shares of the company. Despite beating Q2 earnings estimates, setting FY2026 EPS guidance, announcing a $250M share buyback, and a quarterly dividend with a 4.4% yield, the stock traded down about 6.8% near its 12-month low. Several other hedge funds have also adjusted their positions in the company, with institutional ownership totaling 73.94%.
John Wiley & Sons, Inc. (NYSE:WLY) Q2 2026 Earnings Call Transcript
John Wiley & Sons, Inc. reported mixed Q2 2026 earnings, with strong growth in its research segment and AI initiatives, but declines in its learning business due to external factors like inventory changes at Amazon and soft consumer spending. The company highlighted its leadership in research publishing, significant progress in monetizing AI content licensing, and strategic partnerships with AI innovators. Despite challenges in learning, Wiley reaffirmed its full-year guidance for adjusted EBITDA margin, adjusted EPS, and free cash flow, while narrowing its revenue outlook.
John Wiley & Sons (NYSE: WLY) lifts Q2 2025 earnings on stronger margins
John Wiley & Sons (NYSE: WLY) reported increased profitability for Q2 2025, with net income rising to $44.9 million despite a slight revenue decrease to $421.8 million. Diluted EPS grew to $0.84, primarily driven by cost reductions and the strong performance of its Research segment. The company continued its Global Restructuring Program, incurring $6.1 million in charges for the quarter, and also realized $114.1 million from asset and business sales.
Earnings Flash (WLY) John Wiley & Sons, Inc. Reports Q2 Revenue $421.8M, vs. FactSet Est of $416.4M
John Wiley & Sons, Inc. (WLY) reported its second-quarter revenue reached $421.8 million, surpassing FactSet's estimate of $416.4 million. The company also announced a quarterly cash dividend of $0.355 per share and updated its fiscal 2026 share repurchase allocation to $100 million. Additionally, they maintained their fiscal 2026 adjusted EPS outlook.
John Wiley & Sons Q2 2026 Earnings Preview
This article provides an earnings preview for John Wiley & Sons' Q2 2026 fiscal results. This summary is a placeholder as the actual article content was not provided.
Geode Capital Management LLC Buys 14,401 Shares of John Wiley & Sons, Inc. $WLY
Geode Capital Management LLC increased its stake in John Wiley & Sons (NYSE:WLY) by 1.5%, acquiring an additional 14,401 shares to bring its total holdings to 950,331 shares, valued at approximately $42.4 million. The company's board has authorized a $250 million share repurchase plan, and it offers a quarterly dividend yielding 3.9%. Analyst sentiment is mixed, with an average "Hold" rating for the stock.
Wiley Launches AI Gateway: Industry‑first AI‑native Research Platform | WLY Stock News
Wiley (NYSE: WLY) has launched AI Gateway, the industry's first AI-native research intelligence platform, providing researchers access to trusted scholarly content through a single endpoint. This platform integrates with leading AI tools like Anthropic's Claude, AWS Marketplace, Mistral AI's Le Chat, and Perplexity, ensuring AI-powered research is grounded in validated scholarly sources. It aims to transform scientific discovery by seamlessly incorporating peer-reviewed content into daily AI workflows for universities, corporate R&D, and AI development partners.
Wiley Beats Q1 Expectations, Reaffirms Strong FY2026 Guidance
Wiley reported strong financial results for Q1, surpassing analyst expectations for both revenue and earnings. The company also reaffirmed its positive financial guidance for the full fiscal year 2026, indicating continued confidence in its performance and strategic initiatives. This positive outlook suggests a stable period ahead for Wiley.
Hydrogel‐Based Smart Materials for Wound Healing and Sensing
This review explores the advancements in hydrogel-based smart materials for wound healing and sensing, highlighting their potential for revolutionizing medical treatments and real-time diagnostics. The article details the design principles, fabrication techniques, and diverse applications of these materials, which mimic the natural extracellular matrix to support wound regeneration while addressing issues like material stability and toxicity. It covers innovations such as nanofibers, elastomers, conducting polymers, and their integration with smart monitoring systems and bioactive components for enhanced wound care. The review concludes by discussing challenges and future directions, emphasizing the transformative potential of multifunctional hydrogel-based materials in improving wound healing and continuous monitoring.
Wiley (NYSE:WLY) Beats Q4 Sales Targets
John Wiley & Sons (NYSE: WLY) surpassed Q4 CY2024 revenue and EPS targets, despite a 12.2% year-on-year sales decline to $404.6 million. The company reported a non-GAAP profit of $0.84 per share, significantly above analyst estimates, and reaffirmed its full-year revenue and Adjusted EPS guidance. Wiley's operating margin improved, and free cash flow margin increased, signaling better efficiency despite revenue contraction.
State Street Corp's Strategic Acquisition of John Wiley & Sons Inc Shares
State Street Corp acquired 1,688,156 shares of John Wiley & Sons Inc (NYSE:WLY) on September 30, 2024, at $48.25 per share, significantly boosting its investment in the media-diversified industry. This strategic move increases State Street's holdings in WLY to 3.70% of its portfolio. Despite WLY being currently overvalued according to GF Value, State Street's acquisition suggests a positive long-term outlook for the academic publishing and online education provider.
Wiley shareholders approve executive compensation, re-elect directors By Investing.com
Shareholders of John Wiley & Sons, Inc. (NYSE:WLY) approved executive compensation and re-elected directors at their Annual Meeting on September 26, 2024. The strong shareholder participation, with over 91% of Class A and 97% of Class B shares represented, also ratified PricewaterhouseCoopers LLP as the independent auditor. This decision reflects active shareholder engagement in the company's governance and supports Wiley's strategic direction, particularly following recent financial growth and advancements in AI content licensing.
Wiley: Mild Headwinds, But Heavy Insider Selling Activity (NYSE:WLY)
Wiley reported a 10% year-over-year revenue decline in Q1 FY 2025, primarily due to recent divestitures. Despite improved margins and non-recurring AI content licensing deals, the learning segment's revenue remained flat. The author maintains a Hold rating on the stock, citing unpredictable revenue from non-recurring deals and significant insider selling activity by key executives, which reduces confidence despite a recent 50% share price increase.
Academic Publisher John Wiley & Sons Struggles Despite Recovery Effort
Academic publisher John Wiley & Sons is facing financial struggles despite efforts to recover by divesting non-core business units. While the announcement of strategic actions initially boosted WLY stock, options traders remain pessimistic about the company's future. The company reported disappointing financial results for Q4 and the full fiscal year 2023, attributing the next fiscal year as a "Transition Year" with benefits expected later.
WLY, WLYB INVESTOR NEWS: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages John Wiley & Sons, Inc. Investors With Losses in Excess of $100K to Inquire About Securities Class Action Investigation – WLY, WLYB
The Rosen Law Firm is investigating potential securities class action claims against John Wiley & Sons, Inc. (NYSE: WLY, WLYB) on behalf of investors who suffered losses exceeding $100,000. This investigation follows allegations that Wiley issued materially misleading business information, specifically concerning issues at its Hindawi subsidiary which led to a significant drop in its stock price. Investors are encouraged to contact The Rosen Law Firm to inquire about joining the prospective class action.
John Wiley & Sons Inc. (WLY) Q1 2023 Earnings Call Transcript
John Wiley & Sons Inc. (WLY) reported its Q1 2023 earnings, with revenue growth driven by Research publishing, Research solutions, and Corporate talent development, offsetting declines in university services due to enrollment challenges. Despite a decline in adjusted EBITDA and EPS for the quarter, the company reaffirmed its fiscal 2023 guidance, citing expected restructuring savings and continued investment in key growth areas. The call also addressed the recent OSTP guidance on federally funded research, which aligns with Wiley's open research strategy and is not expected to materially impact its financial trajectory.
Immersive In-Person Field Courses during the Pandemic: Minimizing Risk while Maximizing Efficacy
This article discusses the successful implementation of immersive in-person field courses during the COVID-19 pandemic, focusing on risk mitigation strategies and the achievement of high student learning outcomes. It highlights how a "bubble" approach, comprehensive risk management, and investments in community building allowed for transformative educational experiences without infections or serious incidents. The author suggests this model can be applied to future field education, emphasizing the unique benefits of in-person, extended field courses in fostering student development and addressing disparities in STEM education.
John Wiley & Sons (A Shares) (JW.A) Q2 2022 Earnings Call Transcript
John Wiley & Sons (A Shares) reported strong Q2 2022 earnings, with a 9% revenue increase, 7% adjusted EBITDA growth, and 6% adjusted EPS growth. The company reaffirmed its full-year guidance, driven by growth in research, academic and professional learning, and education services, aligning with ongoing market trends in open research and career-connected education. Brian Napack highlighted the strategic focus on corporate opportunities, talent development, and digital transformation, while CFO John Kritzmacher reviewed the strong first-half performance and capital allocation strategy.
First-In-Human, First-In-Class, Phase I Trial of the Fucosylation Inhibitor SGN-2FF in Patients with Advanced Solid Tumors
This Phase I trial investigated SGN-2FF, a fucosylation inhibitor, as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors. While SGN-2FF showed dose-proportional pharmacokinetics, evidence of target inhibition, and preliminary antitumor activity, the study was terminated due to a higher-than-expected incidence of thromboembolic events. The findings suggest the need for more tumor-specific targeted approaches for future fucosylation inhibitors.
The Costs of Digitizing Education
The COVID-19 pandemic highlighted the costs and challenges of digitizing education, revealing dissatisfaction with online learning outcomes and increased expenses. However, the author argues for a broader perspective, suggesting that technology can improve both educational outcomes and economics by addressing systematic issues in traditional education. Companies like John Wiley & Sons, New Oriental Education, Pearson, and TAL Education are positioned to capitalize on these trends through credentialing, online programs, and innovative content delivery models.
Coronavirus Forces $600 Billion Higher Education Industry Online
The COVID-19 pandemic is forcing the $600 billion higher education industry online as campuses shutter. Universities are scrambling to shift to distance learning, with professors like Analisa Packham at Vanderbilt University quickly adapting to new technologies for teaching and holding virtual office hours. This abrupt transition highlights the challenges and rapid adjustments required for both educators and students in the new remote learning environment.
This UC Riverside professor was ready for the shift to online instruction
Frank Vahid, a professor of computer science at UC Riverside, has been incorporating online instruction and web-based teaching tools into his courses since 2012. He co-developed "zyBooks," interactive textbook replacements, believing STEM students benefit from visual and interactive learning. Vahid also highlights the unique advantages of online learning, such as immediate feedback, animated content, chat box interactions, reduced commutes, and easily integrated guest speakers, which he believes makes it a valuable complement to traditional classroom methods, especially in light of events like the COVID-19 pandemic.
Two-Dimensional Transition Metal Carbides and Nitrides (MXenes): Synthesis, Properties, and Electrochemical Energy Storage Applications
This review comprehensively summarizes the recent advancements in synthesizing, characterizing, and applying two-dimensional transition metal carbides and nitrides, known as MXenes, specifically focusing on their use in electrochemical energy storage. It highlights their unique properties, such as metallic conductivity and pseudocapacitance, which make them promising for supercapacitors, Li-ion, and other alkali-ion batteries. The article also addresses current challenges and future opportunities for MXene-based energy storage solutions.
Polyphosphazenes for the delivery of biopharmaceuticals
This article reviews polyphosphazenes (PPZs) for biopharmaceutical delivery, highlighting their versatile synthesis, biodegradability, and biocompatibility. PPZs have shown promise in gene delivery, protein drug delivery, and vaccination, with some applications advancing to clinical evaluation. Despite challenges in cost-effective synthesis and regulatory history, their positive safety profiles suggest future potential in advanced drug delivery systems.
Wiley opens world-class technology centre in Colombo
John Wiley and Sons, a global leader in research and education, has officially opened a new world-class technology center in Colombo, Sri Lanka, on November 4th. This center is a strategic move to enhance Wiley's digital transformation, focusing on innovative services and products for their partners and customers through cutting-edge technology. The facility will house 200 high-end product engineering and technology operations employees in the "MAGA ONE" building, with plans for further growth in 2020, aiming to empower researchers, learners, universities, and corporations globally.
AMPCo and Wiley announce new publishing partnership
The Australasian Medical Publishing Company Pty Ltd (AMPCo) announced a new partnership with John Wiley and Sons Inc to publish and distribute The Medical Journal of Australia (MJA). This collaboration aims to enhance the journal's global reach, readership, and discoverability beyond the Australian market, leveraging Wiley's technology and extensive customer relationships. The MJA will maintain its editorial independence, with content selection and editing remaining in-house, and will continue to offer free access to research articles related to Aboriginal and Torres Strait Islander health.
Mark Allin Resigns as President and CEO of Wiley
Mark Allin has resigned as President and CEO of John Wiley and Sons, Inc., effective immediately, for family reasons. Matthew Kissner, Chairman of the Board, has been named interim CEO while the company searches for a successor. Allin, a 16-year veteran with Wiley, is credited with leading significant changes and growth during his tenure.
Good Counsel: Meeting the Legal Needs of Nonprofits (SSIR)
This article, an excerpt from "Good Counsel: Meeting the Legal Needs of Nonprofits" by Lesley Rosenthal, details how nonprofits can secure pro bono legal services. It covers identifying legal needs, effectively cultivating and managing pro bono relationships, and the benefits for both nonprofits and volunteer attorneys, including those in transition or still studying. The piece also highlights the role of law students and provides practical advice for soliciting and utilizing legal help.
